2025 ASCO Presentation: Innovent Biologics Announces Updated Data of IBI354 (Novel anti-HER2 ADC) From the Phase 1/2 Clinical Study in Advanced Ovarian Cancer, Breast Cancer and Other Solid Tumors
SAN FRANCISCO and SUZHOU, China, June 3, 2025 /PRNewswire/ -- Innovent Biologics, Inc. ("Innovent") (HKEX: 01801), a world-class biopharmaceutical company that develops, manufactures and commercializes high-quality medicines for the treatment of...
ASCO 2025 Oral Presentation: Innovent Biologics Announces Updated Data of IBI343 (Novel Anti-CLDN18.2 ADC) From the Phase 1 Clinical Study in Patients with Advanced Pancreatic Cancer
SAN FRANCISCO and SUZHOU, China, June 3, 2025 /PRNewswire/ -- Innovent Biologics, Inc. ("Innovent") (HKEX: 01801), a world-class biopharmaceutical company that develops, manufactures and commercializes high-quality medicines for the treatment of...
Creality Celebrates 11th Anniversary with New Visual Identity and 3D Printing Innovations
DETROIT, April 10, 2025 /PRNewswire/ -- Creality, a leading global 3D printing technology brand, celebrated its 11th anniversary at the Renaissance Center of Detroit by the announcement of new products and an updated visual identity. The celebration...
Gr4vy welcomes JustGiving as a new client and introduces Gr4vy Pulse
SAN MATEO, Calif., Dec. 4, 2024 /PRNewswire/ -- Gr4vy , the cloud-native payment orchestration layer, announces JustGiving, the UK's leading online fundraising platform. Through Gr4vy's innovative payment orchestration platform, JustGiving supports...